早期毒性測試的市場規模 - 按方法和最終用戶分類 - 區域前景、競爭策略和細分市場預測（截至 2033 年）

預計2033年，全球早期毒性測試市場規模將成長至25.8億美元，複合年成長率為7.41%。

新化合物的早期毒性評估用於改善藥物開發和現有分子的治療潛力。臨床前階段在許多生物系統中進行，以研究物質的物種、器官和劑量特異性副作用。它以多種方式進行，包括動物體內、實驗室體外測試和電腦模擬。它也用於調查意外接觸化學品的情況。

監管機構已認知到對 COVID-19 治療和疫苗的迫切需求，加快了審查流程並擴大了監管靈活性。這可能透過縮短核准時間並更加重視即時資料共用和協作來改變早期毒性測試的監管格局。疫情的疫情爆發促使學術界、工業界和政府之間加強合作與協作，以加強 COVID-19 的研究工作。

本報告調查了全球早期毒性測試市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場/地區/主要國家的詳細分析、競爭格局主要企業簡介等

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

• 促進因素、抑制因素、機會與挑戰分析
• COVID-19 對市場的影響

第5章 市場變數與展望

• SWOT分析
• PESTEL分析
• 波特五力分析
• 熱圖分析

第6章 競爭狀況

• 製造地、銷售區域、產品類型分佈
• 併購、聯盟、產品發布、合作

第7章 全球早期毒性測試市場：依方法分類

• 全球市場規模、佔有率和預測
• In vivo
• In silico
• In vitro

第8章全球早期毒理學測試市場：依最終用戶分類

• 全球市場規模、佔有率和預測
• 製藥
• 化妝品
• 化學
• 食品
• 其他

第9章 全球早期毒性測試市場預測

• 市場規模/市場佔有率

第10章全球早期毒理學測試市場：按地區

• 市場規模/市場佔有率趨勢/預測
• 亞太地區
• 歐洲
• 中東/非洲
• 北美洲
• 拉丁美洲

第11章 公司簡介

• Agilent Technologies
• Accelrys
• BD bioscience
• Bio-rad
• Bioanalytical Systems
• Charles River Laboratories
• Evotec AG
• Enzo Biochem Inc
• Eurofins Scientific
• 其他

第12章結論

第13章簡稱

第14章參考鏈接

Early Toxicity Testing Market Introduction and Overview

According to SPER market research, 'Early Toxicity Testing Market Size- By Technique, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Early Toxicity Testing Market is predicted to reach USD 2.58 billion by 2033 with a CAGR of 7.41%.

Early toxicity assessment of novel compounds is used to develop medications and increase the therapeutic potential of existing molecules. It is carried out in pre-clinical phases on numerous biological systems to explore the species, organs, and dose-specific harmful effects of a substance. It can be carried out in a variety of ways, including in vivo on animals, in vitro in laboratories with tests, and in silico on a computer. It is also used to research accidental exposures to a chemical.

Recognizing the urgent need for COVID-19 therapies and vaccinations, regulatory agencies accelerated review processes and extended regulatory flexibility. This may have altered the regulatory landscape for early toxicity testing, with shorter approval timelines and a stronger emphasis on real-time data sharing and collaboration. The epidemic prompted collaboration and collaborations among academia, industry, and government to boost COVID-19 research efforts.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Technique, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Agilent Technologies, Accelrys, BD bioscience, Bio-rad, Bioanalytical Systems, Charles River Laboratories, Evotec AG Enzo Biochem Inc, Eurofins Scientific

Global Early Toxicity Testing Market Segmentation:

By Technique: Based on the Technique, Global Early Toxicity Testing Market is segmented as; In vivo, In silico, In vitro.

By End User: Based on the End User, Global Early Toxicity Testing Market is segmented as; Pharmaceuticals industry, Cosmetics industry, Chemicals industry, Food industry, Others.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPER's internal database
  • 2.1.4. Premium insight from KOL's
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges
• 4.2. COVID-19 Impacts of the Global Early Toxicity Testing Market.

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTER's Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Early Toxicity Testing Market Manufacturing Base Distribution, Sales Area, Product Type
• 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Early Toxicity Testing Market

7. Global Early Toxicity Testing Market, By Technique (USD Million) 2020-2033

7.1. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2020-2026

• 7.2. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2027-2033
• 7.3. In vivo
• 7.4. In silico
• 7.5. In vitro

8. Global Early Toxicity Testing Market, By End User (USD Million) 2020-2033

• 8.1. Global Early Toxicity Testing Market Size, Share and Forecast, By End User, 2020-2026
• 8.2. Global Early Toxicity Testing Market Size,Share and Forecast, By End User, 2027-2033
• 8.3. Pharmaceuticals industry
• 8.4. Cosmetics industry
• 8.5. Chemicals industry
• 8.6. Food industry
• 8.7. Others

9. Global Early Toxicity Testing Market Forecast, 2020-2033 (USD Million)

• 9.1. Global Early Toxicity Testing Market Size and Market Share

10. Global Early Toxicity Testing Market, By Region, 2020-2033 (USD Million)

• 10.1. Global Early Toxicity Testing Market Size and Market Share By Region (2020-2026)
• 10.2. Global Early Toxicity Testing Market Size and Market Share By Region (2027-2033)
• 10.3. Asia-Pacific
  • 10.3.1. Australia
  • 10.3.2. China
  • 10.3.3. India
  • 10.3.4. Japan
  • 10.3.5. South Korea
  • 10.3.6. Rest of Asia-Pacific
• 10.4. Europe
  • 10.4.1. France
  • 10.4.2. Germany
  • 10.4.3. Italy
  • 10.4.4. Spain
  • 10.4.5. United Kingdom
  • 10.4.6. Rest of Europe
• 10.5. Middle East and Africa
  • 10.5.1. Kingdom of Saudi Arabia
  • 10.5.2. United Arab Emirates
  • 10.5.3. Qatar
  • 10.5.4. South Africa
  • 10.5.5. Egypt
  • 10.5.6. Morocco
  • 10.5.7. Nigeria
  • 10.5.8. Rest of Middle East & Africa
• 10.6. North America
  • 10.6.1. Canada
  • 10.6.2. Mexico
  • 10.6.3. United States
• 10.7. Latin America
  • 10.7.1. Argentina
  • 10.7.2. Brazil
  • 10.7.3. Rest of Latin America

11. Company Profile

• 11.1. Agilent Technologies
  • 11.1.1. Company details
  • 11.1.2. Financial outlook
  • 11.1.3. Product summary
  • 11.1.4. Recent developments
• 11.2. Accelrys
  • 11.2.1. Company details
  • 11.2.2. Financial outlook
  • 11.2.3. Product summary
  • 11.2.4. Recent developments
• 11.3. BD bioscience
  • 11.3.1. Company details
  • 11.3.2. Financial outlook
  • 11.3.3. Product summary
  • 11.3.4. Recent developments
• 11.4. Bio-rad
  • 11.4.1. Company details
  • 11.4.2. Financial outlook
  • 11.4.3. Product summary
  • 11.4.4. Recent developments
• 11.5. Bioanalytical Systems
  • 11.5.1. Company details
  • 11.5.2. Financial outlook
  • 11.5.3. Product summary
  • 11.5.4. Recent developments
• 11.6. Charles River Laboratories
  • 11.6.1. Company details
  • 11.6.2. Financial outlook
  • 11.6.3. Product summary
  • 11.6.4. Recent developments
• 11.7. Evotec AG
  • 11.7.1. Company details
  • 11.7.2. Financial outlook
  • 11.7.3. Product summary
  • 11.7.4. Recent developments
• 11.8. Enzo Biochem Inc
  • 11.8.1. Company details
  • 11.8.2. Financial outlook
  • 11.8.3. Product summary
  • 11.8.4. Recent developments
• 11.9. Eurofins Scientific
  • 11.9.1. Company details
  • 11.9.2. Financial outlook
  • 11.9.3. Product summary
  • 11.9.4. Recent developments
• 11.10. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links